Skip to main content
Caplight Logo









Ryme Medical

Ryme Medical

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://rymemedical.com

Last Round

Series A

Aug 21, 2024

Total Funding Raised

$14M

Company Overview

Ryme Medical is a medical device company developing a catheter-based interventional therapy designed to treat patients with chronic obstructive pulmonary disease (COPD).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicechronic obstructive pulmonary diseaseCOPDlung denervationinterventional pulmonologycatheter-based therapyminimally invasivemedtechballoon catheterclinical trialinterventional bronchoscopysympathetic nerve ablationpulmonary interventionmedical hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ryme Medical Comparables

Compare Ryme Medical with similar companies based on industry and business-model similarity.

Ryme Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nuvaira
92%
Apreo Health
84%
CSA Medical
83%

Ryme Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 21, 2024
SeedNov 9, 2021

Ryme Medical Investors

Notable investors and investment history

Ryme Medical investors
InvestorRounds
Seroba Life SciencesSeries A
Epidarex CapitalSeries A
Santé VenturesSeries A, Seed
Fogarty InnovationSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2024

    $14M round with participation from Epidarex Capital and Seroba Life Sciences.

  • Nov 9, 2021

    Santé Ventures led the Seed round.

Ryme Medical Filings

Explore SEC and related filing metadata, where available.

Ryme Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ryme Medical's valuation, stock price, and market status.

Is Ryme Medical a public or private company?

Ryme Medical is a private company.

What is the current stock price of Ryme Medical?

Ryme Medical is a private company, so its shares have no public market price. Caplight tracks Ryme Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ryme Medical worth (valuation)?

Valuation information for Ryme Medical is not publicly available.

Can I buy Ryme Medical stock?

Ryme Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ryme Medical's last funding round?

Ryme Medical's most recent funding round was Series A on August 21, 2024.

Who are the main investors in Ryme Medical?

Key investors in Ryme Medical include Santé Ventures.

Will Ryme Medical IPO soon?

No public IPO plans have been announced for Ryme Medical.

How can I track Ryme Medical secondary market activity?

Caplight tracks bids, offers, and trades in Ryme Medical's shares on secondary markets.

Firmographic Details

HeadquartersMountain View, California
Year FoundedN/A
Last FundingAug 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?